Contemporary perspectives on the genetics and clinical use of lipoprotein (a) in preventive cardiology
MM Page, GF Watts - Current Opinion in Cardiology, 2021 - journals.lww.com
MM Page, GF Watts
Current Opinion in Cardiology, 2021•journals.lww.comMeasurement of Lp (a) in the clinical setting contributes to the assessment of ASCVD risk,
and will become more important with the advent of specific Lp (a)-lowering therapies.
Knowledge of an individual patient's genetic predisposition to increased Lp (a) appears to
impart little or not additional clinical value beyond Lp (a) particle concentration.
and will become more important with the advent of specific Lp (a)-lowering therapies.
Knowledge of an individual patient's genetic predisposition to increased Lp (a) appears to
impart little or not additional clinical value beyond Lp (a) particle concentration.
Summary
Measurement of Lp (a) in the clinical setting contributes to the assessment of ASCVD risk, and will become more important with the advent of specific Lp (a)-lowering therapies. Knowledge of an individual patient's genetic predisposition to increased Lp (a) appears to impart little or not additional clinical value beyond Lp (a) particle concentration.
Lippincott Williams & Wilkins以上显示的是最相近的搜索结果。 查看全部搜索结果